![]() Prior results do not guarantee a similar outcome. Our attorneys have been instrumental in implementing corporate reforms and recovering millions of dollars on behalf of defrauded investors.Īttorney Advertising. Halper Sadeh LLC represents investors all over the world who have fallen victim to securities fraud and corporate misconduct. Genentech/Roche, Immunomedics/ Gilead, Bristol-Myers Squibb, Eisai, Nanostring, Puma, Sanofi, Puma, Silverback Therapeutics, G1 Therapeutics, Athenex. Silverback is a biopharmaceutical company focused on leveraging its proprietary ImmunoTAC technology platform to develop systemically delivered and tissue targeted therapeutics for the. On behalf of Silverback shareholders, Halper Sadeh LLC may seek increased consideration for shareholders, additional disclosures and information concerning the proposed transaction, or other relief and benefits. The investigation concerns whether Silverback and its board violated the federal securities laws and/or breached their fiduciary duties to shareholders by failing to, among other things: (1) obtain the best possible consideration for Silverback shareholders and (2) disclose all material information necessary for Silverback shareholders to adequately assess and value the merger consideration. Under the terms of the merger agreement, assuming that Silverback’s net cash at closing is $240 million, Silverback equity holders are expected to own approximately 37% of the combined company. (NASDAQ: SBTX) and ARS Pharmaceuticals, Inc. New York, New York-Halper Sadeh LLC, an investor rights law firm, is investigating whether the merger of Silverback Therapeutics, Inc. ![]() SBTX STOCK ALERT: HALPER SADEH LLC IS INVESTIGATING WHETHER THE MERGER OF SILVERBACK THERAPEUTICS, INC. Seattle biotech startup Silverback Therapeutics continues to raise capital to support development of its therapies for cancer, fibrosis, and other conditions. Silverback Therapeutics 7,262 followers 11mo Activation of TLR8 can elicit a robust immune response, critical for mounting productive anti-tumor and anti-viral responses, through a multi-pronged. ![]()
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |